Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has a beta value of 1.12 and has seen 2.23 million shares traded in the recent trading session. The company, currently valued at $1.84M, closed the recent trade at $0.38 per share which meant it lost -$0.09 on the day or -20.23% during that session. The VRPX stock price is -2131.58% off its 52-week high price of $8.48 and -21.05% below the 52-week low of $0.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 84530.0 shares traded. The 3-month trading volume is 1.34 million shares.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
Sporting -20.23% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the VRPX stock price touched $0.38 or saw a rise of 26.97%. Year-to-date, Virpax Pharmaceuticals Inc shares have moved -88.26%, while the 5-day performance has seen it change -24.19%. Over the past 30 days, the shares of Virpax Pharmaceuticals Inc (NASDAQ:VRPX) have changed -54.65%. Short interest in the company has seen 0.39 million shares shorted with days to cover at 6.89.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could jump 87.33% from the levels at last check today.. The projected low price target is $3.0 while the price target rests at a high of $3.0. In that case, then, we find that the latest price level in today’s session is -689.47% off the targeted high while a plunge would see the stock gain -689.47% from the levels at last check today..
Virpax Pharmaceuticals Inc (VRPX) estimates and forecasts
The company’s shares have lost -89.36% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -20.69% over the past 5 years.
VRPX Dividends
Virpax Pharmaceuticals Inc is expected to release its next earnings report on 2024-Aug-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
Insiders own 2.57% of the company shares, while shares held by institutions stand at 0.21% with a share float percentage of 0.21%. Investors are also buoyed by the number of investors in a company, with Virpax Pharmaceuticals Inc having a total of 8.0 institutions that hold shares in the company. The top two institutional holders are PARALLEL ADVISORS, LLC with over 1.0 shares worth more than $1.0. As of 2024-06-30, PARALLEL ADVISORS, LLC held 0.0001% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . As of Jun 30, 2024 , the former fund manager holds about 0.57% shares in the company for having 6.63 shares of worth $2462.0 while later fund manager owns 4.33 shares of worth $1609.0 as of Aug 31, 2024 , which makes it owner of about 0.37% of company’s outstanding stock.
